1541 - 1550 of 7916 Results
Title
Year
- Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease2022OPENTitle: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 7Start Page: e2223821End Page: e2223821Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdfCitation Count: 7
- Disruption of Dopamine Receptor 1 Localization to Primary Cilia Impairs Signaling in Striatal Neurons2022OPENTitle: Disruption of Dopamine Receptor 1 Localization to Primary Cilia Impairs Signaling in Striatal NeuronsJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 35Start Page: 6692End Page: 6705Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1523/jneurosci.0497-22.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/35/6692.full.pdfCitation Count: 15
-
OPENTitle: Shared mechanisms across the major psychiatric and neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31873-5Best OA location URL: https://www.nature.com/articles/s41467-022-31873-5.pdfCitation Count: 80
- Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion2022OPENTitle: Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal ConversionJournal Name: Cellular ReprogrammingPublisher: Mary Ann Liebert IncVol: 24Issue #: 5Start Page: 304End Page: 313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1089/cell.2021.0200Best OA location URL: https://doi.org/10.1089/cell.2021.0200Citation Count: 1
-
OPENTitle: Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 807End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26462Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588516Citation Count: 18
-
RESTRICTEDTitle: Studying cognitive function in patients with a long-standing diagnosis of SWEDDJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 441Issue #:Start Page: 120353End Page: 120353Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120353Citation Count: 1
- Association between Functional Connectivity of Entorhinal Cortex and Olfactory Performance in Parkinson’s Disease2022OPENTitle: Association between Functional Connectivity of Entorhinal Cortex and Olfactory Performance in Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 8Start Page: 963End Page: 963Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12080963Best OA location URL: https://www.mdpi.com/2076-3425/12/8/963/pdf?version=1658485938Citation Count: 2
- Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies2022RESTRICTEDTitle: Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathiesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00357-0Best OA location URL: https://www.nature.com/articles/s41531-022-00357-0.pdfCitation Count: 48
-
RESTRICTEDTitle: Profiling the NOTCH2NLC GGC Repeat Expansion in Parkinson's Disease in the European PopulationJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2161End Page: 2162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29155Citation Count: 3
- Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions2022RESTRICTEDTitle: Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future DirectionsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1593End Page: 1604Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29126Best OA location URL: https://discovery.ucl.ac.uk/10155740/1/Underrepresented%20Populations%20in%20Parkinsons%20Genetics%20Research.pdfCitation Count: 31